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INTRODUCTION
Compensatory renal growth symposium: An introduction
The subject of compensatory renal hypertrophy and regener-
ation has received relatively little attention from nephrologists
and renal physiologists, Perusal of the table of contents in any
major kidney-oriented textbook reveals little or no space devot-
ed to it. Symposia concerned principally with renal hormones
or metabolism rarely mention a circulating renotropin and/or a
system regulating compensatory renal hypertrophy and regen-
eration of damaged tissue.
Compensatory renal hypertrophy with hyperplasia is the
enlargement and new formation of cells following loss of renal
mass that cannot be replaced in situ. The most common
example is the hypertrophy and hyperplasia of the remaining
kidney tissue after surgical extirpation of one kidney (unilateral
nephrectomy). Regeneration occurs when the original renal
mass returns both anatomically and functionally via hyperplasia
toward its original state following damage, such as seen in acute
tubular necrosis. Obviously, both processes, hypertrophy and
regeneration, could result from the same, overlapping, or even
an entirely different mechanism. For simplicity, we will refer to
both processes under the single term, compensatory renal
growth (CRG).
The first major symposium devoted to CRG was held in
Galveston, Texas, in 1968; the proceedings were published in a
book entitled, Compensatory Renal Hypertrophy edited by Drs.
W. W. Nowinski and R. J. Goss [1]. Eight years later, a
conference concerned in part with biochemical and molecular
responses to loss of renal mass was held in Lausanne, Switzer-
land. The proceedings of this meeting on Renal Adaptation to
Nephron Loss were published originally in the Yale Journal of
Biology [2] and later by the S. Karger Company, Switzerland
[3]. Now, 6 years later, we have attempted to update the subject
by gathering papers on various aspects of CRG written by
experts in the field. Each paper has been arbitrarily placed in
one of three general sections. The first section contains contri-
butions principally concerned with the physiology and bio-
chemistry of CRG. The second section includes those works
pertaining to the existence of a renotropic factor(s) which
specifically incites and/or regulates CRG. Perhaps, the greatest
gains have been made in this area since the last symposium was
held in Switzerland. The third section is devoted to two
disorders that have been associated with CRG, namely hyper-
tension and diabetes mellitus. Assuming that a renotropic factor
exists, the additional biochemical and physiological influences
of renotropin could be an area where future research may prove
beneficial.
Biochemistry and physiology of CRG
To derive an extensive background concerning early history
and the effects of diets and other environmental factors on
DNA, RNA, and other aspects of biochemistry in CRG, one
might start with the contributions in the first and second
symposia [1—3] and other earlier writings [4, 5].
In brief, survival of the organism is dependent, to a great
extent, on the ability of renal hypertrophy and/or hyperplasia to
return viable renal tissue after excessive destruction of renal
parenchyma. Following unilateral nephrectomy, an early in-
crease in wet and dry renal mass is noted. Changes in bulk RNA
may be seen by 24 hr, followed later by enhancement of protein
and DNA synthesis (Fig. 1). Changes are also noted in mitotic
activity, and polysomal composition [6]. Uptake of radioactive
precursor into RNA are detectable early. Toback, Smith and
Lowenstein [7] found increases in phospholipid synthesis (cho-
line incorporation into lipids) within 5 mm of unilateral nephrec-
tomy in mice. The latter probably reflects synthesis of new cell
membrane.
Three papers in the current symposium add to our knowledge
concerning the biochemistry of CRG. Ouellette discusses the
possibility that analysis of renal mRNA during renal growth has
not been sufficiently thorough. The mRNA's that regulate gene
expression and growth may not be required at abundant levels;
thus, they might not be detected by methods used in previous
studies. Accordingly, he feels that other methodology must be
developed and utilized. It is his opinion that recombinant DNA
technology to investigate genetic regulation during compensa-
tory hypertrophy is certain to define renal growth at the
molecular level.
Austin et al in this symposium present data indicating that
polyamine metabolism may play an important role in CRG.
Their work underscores the rapid inducibility of ornithine
decarboxylase, the rate-limiting enzyme for polyamine biosyn-
thesis. Further, their findings with an in vitro assay using
ornithine decarboxylase activity as a growth index support the
existence of a circulating renal growth regulator secondary to
unilateral nephrectomy.
Bergeron and Hoang examine the role of adenosine and
adenosine deaminase in CRG. When complete inhibition of
adenosine deaminase was achieved by injecting coformycin, a
specific adenosine deaminase inhibitor, renal adenosine in-
creased and CRG took place. The authors postulate from their
in vivo and in vitro studies that CRG could be due to the
intracellular action of adenosine acting as a secondary messen-
ger for cell proliferation.
Two papers concerned with physiological aspects of CRG are
included. The paper written by Zelman, Zenser, and Davis
deals with CRG following unilateral renal obstruction. The
authors point out that both the obstructed and contralateral
kidneys grow. In the kidney undergoing obstruction, renal mass
increases over 7 to 10 days, followed by a progressive decline in
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Fig. 1. Changes in RNA and DNA fbllowing unilateral nephreciomy
versus sham operation. Results are expressed as a percentage increase
relative to concurrent sham. Symbols are: •, total RNA; A, total DNA;
, RNA/DNA; , P < 0.05; , P < 0.01. The figure was taken from
work of Austin et at reported in this symposium, but it has not been
published with the manuscript.
mass. Growth is more obvious in younger than in older animals.
They suggest that growth of the obstructive kidney, due largely
to proliferation of interstitial fiberblasts and macrophages, may
be a local response to injury. Fibroblasts, cultured from the
medulla of the obstructive kidney, show an increased growth
response. In contrast, the contralateral kidney enlarges as a
result of hyperplasia and hypertrophy of the renal parenchyma
with the onset of the growth process delayed relative to the
obstructive kidney. The differential growth characteristics of
the two kidneys in this model make this an interesting investiga-
tive tool for future studies on hypertrophy and hyperplasia.
Hayslett's paper stresses a point noted by Zelman, Zenser
and Davis, that is, CRG is not as great in older animals
compared to younger ones. This should not surprise clinicians
who have observed the superior renal regeneration and recov-
ery in their younger patients following acute renal failure.
Precise reasons for the relatively poor growth in older kidneys
are unknown. The previously described renotropic factor and
the tissue response to it could be involved. Since a kidney
extract and a serum factor that could incite and regulate renal
growth have been described in rats, my laboratory compared
both factors in young and old rats after unilateral nephrectomy
in preliminary studies (Fig. 2). The factors obtained from older
rats weighing an average of 426 g were compared to those of
younger rats, weighing an average of 241 g. Twenty hours after
uninephrectomy, sera removed from the young unilaterally
nephrectomized rats significantly increased thymidine incorpo-
ration into DNA of incubating rat renal slices (23%). In con-
trast, sera obtained from the old breeder rats stimulated incor-
poration only 7%, an average that was not significantly different
from control. When both sera and extracts were taken from
these two different age groups of rats, the combination from
young rats stimulated thymidine incorporation into DNA nearly
60% and was elevated significantly above control, whereas
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Fig. 2. Percentage qf change in incubating rat kidney fragments
induced by adding vera and/ar extracts from young and old rats 20 hr
after unilateral nephrectomy or sham operation. The average SEM of
six rats is shown. Symbols are: , old breeder rats (426 g 29 sEM); rn.
younger rats (241 12 5EM); +, P <0.05; •. P <0.01, compared to
fragments incubating in neither sera nor extracts (pair analysis); 0. P <
0.05 compared to products from old rats (group analysis).
products from older rats failed to stimulate isotope incorpo-
ration. The last set of bars in Figure 2 shows that when the
stimulatory factors in sera were excluded, extracts from the
younger rats still significantly enhanced thymidine incorpo-
ration into DNA. Accordingly, it would appear that both sera
and tissue activators from younger rats can enhance certain
aspects of renal growth in contrast to products obtained from
older rats.
Renotropic.factor(s)
In the 6 years since the previous symposium on compensa-
tory renal growth [2, 31 the greatest gains have probably been
made in ascertaining the presence of a specific substance,
renotropin, that stimulates renal growth. The possibility that a
specific circulating renal growth factor exists is strengthened by
the finding of specific mitogenic stimulators of growth for other
organs. Patt and Houck emphasize in their paper that the three
principal forms of growth, that is embryonic growth, wound-
repair compensatory hypertrophy, and neoplastic growth. are
capable of being stimulated through circulating humoral factors.
They discuss the more commonly accepted specific organ
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stimulators such as epidermal growth factor, fibroblast growth
factor, and so forth.
Malt summarized pros and cons for the existence of renotro-
pin, by discussing the evidence behind the theory that regula-
tors of CR0 are probably humoral. It is his opinion that the best
evidence for renotropin's existence can be derived from parabi-
otic studies. He points out that once compensatory hypertrophy
takes place, separation of the rat pairs returns kidney mass
toward baseline, suggesting that renotropin must be present to
maintain hypertrophy.
While Dr. Malt reviews many of the shortcomings of different
experimental designs, the positive results from different labora-
tories [81 using multiple techniques and indices of growth make
the existence of renotropin highly likely despite these problems.
In their studies, Harris, Hise, and Best investigated a reno-
tropic factor in urine. Because the kidney is responsible for
diverse functions excretory, metabolic, and humoral — these
authors propose that reduction of one or a combination of these
functions probably signals CRG. In this study, they use a
previously described half-urine reinfusion technique [9]. Their
earlier studies had demonstrated that reinfusion of urine over 24
hr increases renal protein synthesis. In their present study, they
show that reinfusion, even over 3 hr, can increase thymidine
incorporation into DNA and choline incorporation into phos-
pholipids. In addition, adding urine directly to incubating renal
fragments stimulates growth. The urinary growth factor that is
retained in dialyzed urine and is not deactivated by boiling has a
molecular weight of greater than 10,000. The preceding obser-
vation duplicates those found for the serum factor [8] (Gaydos,
Goldin, Jenson, Gersten, Boedecker, Bartz, and Preuss, sub-
mitted for publication). Again, like the serum factor, adding
more urine causes a finite increase in the growth which cannot
be increased further [10]. As a final similarity, the growth factor
is not produced by kidneys since removal of one kidney did not
enhance the urine effect [81. The comparisons suggest that the
urine and serum factors may be the same, at least in part. Harris
and Best postulate that removal of renal mass decreases excre-
tion of the growth factor and raises its circulatory concentra-
tion, which incites renal growth.
Only a few laboratories have been able to show the presence
of renotropin through in vitro assay [8]. Amplification of the
growth indices of in vitro assays is essential because the small
stimulation hinders extensive investigations concerning the
physiology and biochemistry of renotropin. Yarnamoto, Kane-
take, and Yamada have developed an economical tissue culture
system in which they synchronize cell growth to maximize the
renotropic stimulation in serum from unilaterally nephrecto-
mized rabbits. Using their methodology, they show a maximal
stimulation from serum 7 to 10 days after uninephrectomy; the
magnitude of stimulation was three- to fourfold above baseline.
This assay system with its higher degree of amplification may
represent a significant breakthrough which will allow more
extensive studies and purification of the factor.
Other aspects of CRG phenomena
The final section of this symposium examines the association
between CRG and hypertension — diabetes mellitus. Because
many of his experimental models caused both CR0 and hyper-
tension, Braun Menendez, to whom the symposium is dedicat-
ed, postulated that renotropin not only initiates and/or regulates
renal growth, but is the basis for some forms of hypertension.
According to his hypothesis, hypertension develops when the
concentrations of renotropin rise secondary to the loss of renal
mass. Other studies support the viability of this theory. Green-
wood, Nassim, and Taylor [11] noted that normal kidneys had
to be removed to maintain Goldblatt hypertension. They pro-
posed that the normal kidney either excretes or destroys the
renal pressor substance. Later, Fregley and Field [12] noted a
correlation between kidney size and hypertension, that is, the
greater the kidney weight, the higher the blood pressure.
Furthermore, Japanese investigators have shown that unilateral
nephrectomy causes an even greater elevation in blood pressure
of the spontaneously hypertensive rat (SHR) [13].
Braun Menendez felt that the weakest link in his hypothesis
was that no definitive proof was available for the existence of
renotropin [14, 15]. Obviously, his hypothesis was proposed
prior to the development of the various assays for renotropin
[8]. Preuss and Goldin follow renotropic activity in the sera of
SHR rats. Rats between 6 and 16 weeks of age, with untouched
kidneys, showed a relatively enhanced renotropic activity in
their sera when compared to normotensive rats. Other aspects
of the CRG system seemed to be normal. They postulated that
to maintain normal renal size, these rats may require a higher
level of circulating renotropin. This, in return influences blood
pressure regulation in some manner. This study deserves fur-
ther investigation in light of Braun Menendez's early postulate
[14, 15].
Renal growth during diabetes has long interested many
investigators. Renal mass and glomerular filtration rate are
increased in the kidneys of young insulin-dependent diabetic
patients. In his investigation with experimentally induced dia-
betes mellitus in rats, Seyer-Hansen corroborates that diabetes
mellitus increases renal weight and gomerular filtration rate.
This CRG is similar biochemically and physiologically to that
following unilateral nephrectomy, but could not be secondary
to the mechanism proposed in the symposium paper by Harris,
Hise, and Best since GFR is augmented in the face of growth.
Further, combined diabetes mellitus and unilateral nephrecto-
my can augment renal growth even greater than with one state
alone. Seyer-Hansen finds a very close association between
circulating glucose levels and kidney size. This model of renal
growth, which may or may not be different from that seen
following unilateral nephrectomy, is interesting because the
pathogenesis of diabetic nephropathy may relate to CRG [161.
As a final point, the development of CRG in diabetes mellitus
suggests that glucose, glucagon, and/or insulin could be in-
volved in CRG.
While the importance of renotropin has been studied exten-
sively in rats and rabbits, it is comforting to find a renotropic
factor present in humans. The work of Yamada et al shows the
existence of a human renal growth factor in sera from unilateral-
ly nephrectomized patients. Six of the sera were derived from
renal cancer-bearing patients and two from renal transplant
donors.
Knowledge concerning CRG and its various effects has
grown slowly over the years. Since the last major symposium
on the subject [2, 3], many investigators have searched for a
renotropic agent. Its existence has been suggested by evidence
gathered from many laboratories using multiple different tech-
niques and indices of growth. Whether this agent is a common,
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established hormone with more apparent functions or one not
yet identified and named is unknown. If it plays a role in
hypertension and/or is responsible for diabetic renal growth and
nephropathy remains to be established. Findings of Shames,
Corriere, and Berkowitz [171 suggest that CRG influences renal
sodium handling, and Garcia-Caceres and Ortega [181 hypothe-
size that CRG could play a role in pathogenesis of certain renal
diseases. Accordingly, it is hoped that this symposium will
provide impetus for further investigations along these lines.
When future symposia are held, we may have clearer knowl-
edge of the factors controlling CRG and their relation to other
states.
HARRY G. PREUSS
Washington, D.C.
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Note added in proof
The reference cited as submitted for publication in the Renotropic
factor(s) section by GAYDOS DS, GOLOIN H, JENSON B. GERSTEN D,
BOEOECKER B, BARTZ C, and PREUSS HG has recently been accepted in
Renal Physiology with the title, 'Partial characterization of a renotro-
pie factor."
